Results 121 to 130 of about 136,562 (360)
This study introduces a novel transdermal delivery system of molecular hydrogen for postoperative pain relief and wound healing. This system utilizes sustained‐release photothermal microneedles to integrate hydrogen‐releasing nanoparticles and temperature‐responsive microspheres, achieving acid‐responsive hydrogen release and controlled drug release ...
Aining Zhang+8 more
wiley +1 more source
Enfermedad hemolítica perinatal Perinatal hemolytic disease
La enfermedad hemolítica perinatal (EHPN) es una afección inmunológica aloinmune contra antígenos de origen paterno presentes en los hematíes fetales y del recién nacido. Se han reportado numerosos aloanticuerpos dirigidos contra antígenos eritrocitarios
María del Rosario López de Roux+1 more
doaj
Biochemical Variants of Glucose-6-Phosphate Dehydrogenase Giving Rise to Congenital Nonspherocytic Hemolytic Disease [PDF]
Ernest Beutler+2 more
openalex +1 more source
The schematic diagram delineates the chondroprotective effects of Ca‐bMSN in OA models. The upper portion of the diagram depicts the synthesis process of Ca‐bMSN. The lower section illustrates the post‐injection of Ca‐bMSN in joint cavity, catalpol released and subsequently mediates the reduction of oxidative stress, ECM catabolism, apoptosis, and ...
Zhenwei Zhou+14 more
wiley +1 more source
Pathogenesis of Hemolytic Anemia in Homozygous Hemoglobin C Disease* [PDF]
Samuel Charache+4 more
openalex +1 more source
Hemolytic Disease of The Newborn
Hemolytic disease of the newborn (HDN), or erythroblastosis fetalis, primarily impacts rhesus-positive fetuses born to rhesus-negative mothers. The condition arises when maternal antibodies, formed after alloimmunization due to rhesus or ABO blood type incompatibility, attack fetal red blood cells.
openaire +1 more source
B‐OMVs, nanoscale vesicles derived from BCG, are identified as effective and safe inducers of trained immunity that protect against sepsis. Through TLR2‐mediated metabolic and epigenetic reprogramming of hematopoietic stem cells, B‐OMVs enhance inflammatory response and phagocytic activity.
Yuan Gong+16 more
wiley +1 more source
Urinary Iron Excretion and Renal Metabolism of Hemoglobin in Hemolytic Diseases [PDF]
David Sears+4 more
openalex +1 more source
Zheng et al. designed a tumor microenvironment (TME)‐responsive nanosystem, HmBMH@MSA‐2. It targets tumors, releases MSA‐2 and Mn ions in high glutathione (GSH) conditions, achieving STING agonist delivery and MRI. The nanosystem promotes chemodynamic therapy (CDT), achieves radiosensitization, and activates the cGAS‐STING pathway.
Yinfei Zheng+11 more
wiley +1 more source
Congenital Hemolytic Disease Associated with Red Cell Inclusion Bodies, Abnormal Pigment Metabolism and an Electrophoretic Hemoglobin Abnormality [PDF]
Joseph L. Scott+3 more
openalex +1 more source